NeuroMetrix (NASDAQ:NURO) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of NeuroMetrix (NASDAQ:NURO) in a research note released on Monday. The firm issued a sell rating on the medical device company’s stock.

NeuroMetrix Trading Up 0.3 %

Shares of NURO opened at $3.85 on Monday. NeuroMetrix has a 1 year low of $2.70 and a 1 year high of $9.68. The stock has a market cap of $7.74 million, a P/E ratio of -0.61 and a beta of 2.28. The stock’s 50-day moving average price is $4.10 and its two-hundred day moving average price is $3.71.

NeuroMetrix (NASDAQ:NURO) last released its earnings results on Thursday, February 22nd. The medical device company reported ($1.43) EPS for the quarter. NeuroMetrix had a negative net margin of 151.51% and a negative return on equity of 39.85%. The firm had revenue of $1.32 million during the quarter.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in NeuroMetrix stock. Cerity Partners LLC acquired a new stake in NeuroMetrix, Inc. (NASDAQ:NURO) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 30,000 shares of the medical device company’s stock, valued at approximately $108,000. Cerity Partners LLC owned approximately 2.80% of NeuroMetrix at the end of the most recent reporting period. 19.40% of the stock is currently owned by institutional investors and hedge funds.

About NeuroMetrix

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.